IIA
ABBV icon

ICW Investment Advisors’s AbbVie ABBV Stock Holding History

ICW Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.28M Sell
24,269
-185
-0.8% -$41K 1.91% 8
2025
Q4 		$5.59M Sell
24,454
-443
-2% -$101K 2.03% 9
2025
Q3 		$5.76M Buy
24,897
+665
+3% +$135K 2.07% 5
2025
Q2 		$4.5M Sell
24,232
-74
-0.3% -$13.8K 1.78% 11
2025
Q1 		$5.09M Sell
24,306
-10
-0% -$1.94K 2.07% 8
2024
Q4 		$4.32M Sell
24,316
-140
-0.6% -$25.7K 1.8% 9
2024
Q3 		$4.83M Sell
24,456
-267
-1% -$49.8K 2.01% 7
2024
Q2 		$4.24M Sell
24,723
-466
-2% -$77.2K 1.92% 7
2024
Q1 		$4.59M Buy
25,189
+211
+0.8% +$36.4K 2.04% 4
2023
Q4 		$3.87M Buy
24,978
+278
+1% +$40.5K 1.88% 7
2023
Q3 		$3.68M Buy
24,700
+492
+2% +$72.2K 1.98% 7
2023
Q2 		$3.26M Buy
24,208
+455
+2% +$66.7K 1.75% 8
2023
Q1 		$3.79M Buy
23,753
+391
+2% +$59.8K 2.15% 4
2022
Q4 		$3.78M Sell
23,362
-151
-0.6% -$23.2K 2.27% 1
2022
Q3 		$3.16M Buy
23,513
+87
+0.4% +$12.5K 2.12% 3
2022
Q2 		$3.59M Buy
23,426
+8
+0% +$1.22K 2.28% 2
2022
Q1 		$3.8M Buy
23,418
+65
+0.3% +$9.44K 2.19% 3
2021
Q4 		$3.16M Buy
23,353
+179
+0.8% +$21.1K 1.77% 10
2021
Q3 		$2.5M Buy
23,174
+290
+1% +$33.1K 1.61% 13
2021
Q2 		$2.58M Buy
22,884
+145
+0.6% +$16.3K 1.68% 9
2021
Q1 		$2.46M Buy
22,739
+93
+0.4% +$9.95K 1.69% 8
2020
Q4 		$2.38M Sell
22,646
-150
-0.7% -$14.4K 1.71% 8
2020
Q3 		$2M Buy
22,796
+301
+1% +$28.3K 1.5% 11
2020
Q2 		$2.21M Sell
22,495
-113
-0.5% -$9.95K 1.8% 8
2020
Q1 		$1.72M Buy
22,608
+292
+1% +$24.9K 1.64% 7
2019
Q4 		$1.98M Buy
+22,316
New +$1.85M 1.6% 9

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ICW Investment Advisors's ABBV Position: Q1 2026 in Review

ICW Investment Advisors reduced its AbbVie (ABBV) stake by 0.76% in Q1 2026, selling an estimated $41K and leaving 24,269 shares worth $5.28M. The position accounts for 1.91% of the portfolio, ranked #8.

ICW Investment Advisors first reported a position in ABBV in Q4 2019 and has held it in 26 quarters since. The position peaked at $5.76M in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • ICW Investment Advisors held 24,269 shares of AbbVie worth $5.28M as of Q1 2026.
  • ICW Investment Advisors sold 185 AbbVie shares in Q1 2026, an estimated $41K.
  • AbbVie made up 1.91% of ICW Investment Advisors's portfolio in Q1 2026, its #8 holding.
  • ICW Investment Advisors first reported a position in AbbVie in Q4 2019 and has held it in 26 quarters since.
  • ICW Investment Advisors's AbbVie position peaked at $5.76M in Q3 2025.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on ICW Investment Advisors's 13F filing for Q1 2026, filed 11 May 2026.